• Antipsychotic Drugs market
    Pharmaceutical and Healthcare

    Antipsychotic Drugs Market size, share, growth and Forecast

    Antipsychotic Drugs Market Market Overview: In the forecast period from 2018 to 2023, the global market for antipsychotic drugs is expected to register a CAGR of 3.5%. Drugs used in the treatment of psychosis, including schizophrenia and bipolar disorder, are antipsychotic medicines. The increase in the prevalence of mental health disorders among the population such as schizophrenia and bipolar disorder is a major driver of growth for the market. According to data published by the American Anxiety and Depression Association, about 6.7% of the U.S. population aged 18 years and older suffered from major depression. Due to the high prevalence of psychosis and related disease conditions, North America is expected…

  • Biguanide Market
    Pharmaceutical and Healthcare

    Biguanide Market Size, Share, Trends and Analysis

    Biguanide Market Market Overview: Biguanides are one of the most widely used anti-diabetic oral medicines. Significant growth in the global type 2 diabetic population is the prominent driver for biguanides market growth. Because of its low price compared to other diabetic drugs, the drug is most preferred. Metformin is the active pharmaceutical ingredient for the biguanide class of drugs. From 2018 to 2023, the biguanides market is anticipated to see a development of around 15.3 %. It is expected that the global biguanide market will reach USD 4.4 billion by 2023. Metformin helps patients with type 2 diabetes control high blood sugar levels. Preventing damage to the kidney, blindness, nerve…

  • Alopecia Treatment market
    Pharmaceutical and Healthcare

    Global Alopecia Treatment(Hair Loss) Market Analysis and Forecast

    Global Alopecia Treatment(Hair Loss) Market Global Alopecia Treatment Hair Loss Market Overview: The global alopecia treatment hair loss market is anticipated to record a 5.2% CAGR over the forecast era, 2018-2023. Alopecia is also called hair-loss or baldness, a disease that relates to hair loss from the head or any part of the body. It can happen male and female, and at any age. There are five main alopecia kinds: alopecia areata, androgenic alopecia, cyatricial alopecia, traction alopecia, and alopecia totalis. Alopecia areata is a prevalent autoimmune disorder where the bodys immune system attacks healthy hair follicle, leading to hair loss. Increasing R&D Initiatives and New Product Approvals: In recent…

  • Scar Treatment market
    Pharmaceutical and Healthcare

    Global Scar Treatment Market Size, Share, Trends and Forecast

    Global Scar Treatment Market Global Scar Treatment Market Overview: The scar treatment market is anticipated to grow by about 9.8% over the forecast period from 2018 to 2023. Any burn injury or other trauma, including surgery, can cause a scar. The appearance and treatment of scar after injury depends on multiple factors that reduce scars, but dont remove them completely. Its market is motivated mainly by road accidents, burn injuries, technological development, and aesthetics. Based on geographical analysis, North America is anticipated to maintain dominance due to strong demand for aesthetics, early implementation of sophisticated techniques, and social awareness. Increased road accidents and burn injuries drive primarily Scar Treatment Market:…

  • Empty Capsules Market
    Pharmaceutical and Healthcare

    Global Empty Capsules Market Analysis and Forecast

    Global Empty Capsules Market Global Empty Capsules Market Overview: The global empty capsules market is anticipated to record a 7.1% CAGR over the forecast era, 2018-2023. The empty capsule is a cancer therapy chemotherapy medicine. A pharmaceutical capsule refers to encapsulation of dosage forms in a relatively stable shell, allowing them to be taken orally or used as suppositories. There are two main types of capsules— hard-shelled capsules containing dry, powdered ingredients or miniature pellets made by extrusion or spheronization processes. Rising geriatric population to drive Capsule-based Formulations Demand: A persons number of drugs in a lifetime increases almost linearly with age. Studies in separate environments showed that older adults…

  • Human Insulin market
    Pharmaceutical and Healthcare

    Human Insulin Market Analysis and Forecast

    Human Insulin Market Market Overview: In 2019-2024 the human insulin market is anticipated to record a CAGR of 4.93% and is estimated to achieve USD 25.7 billion by 2019. Diabetes is usually regarded as a lifestyle disease. The incidence of this disease has risen over time, with the rise of the worlds population. Around 100 million people around the world, including all those with Type 1 diabetes and 10-25 percent of those with Type 2 diabetes, need insulin. While insulin has been used for more than 90 years in the treatment of diabetes, more than half of people who require insulin today still have no access to it. People with…

  • Iron Deficiency Anemia Therapy market
    Pharmaceutical and Healthcare

    Iron Deficiency Anemia Therapy Market Size, Share, Trends and Forecast

    Iron Deficiency Anemia Therapy Market Market Overview: Iron deficiency anemia is a prevalent disorder that affects kids and young females worldwide in particular. Iron deficiency is a significant issue in developed nations, such as the US, Canada, the UK and Europe. In addition, iron deficiency anemia is often exacerbated by malaria and other worm infections in developing countries. In addition, iron deficiency anemia is often exacerbated by malaria and other worm infections in developing countries. The growing danger of hemodilution in pregnant females is an important driver for this industry. The need to decrease the burden of anemia with iron deficiency resulted to an rise in the demand for therapy,…

  • Acute Lymphoblastic Leukemia market
    Pharmaceutical and Healthcare

    Acute Lymphoblastic Leukemia Therapeutics Market

    Acute Lymphoblastic Leukemia Therapeutics Market Acute Lymphoblastic Leukemia Therapeutics Market Overview: One of the major factors responsible for the growth of this market is the growing occurrence of Acute Lymphoblastic Leukemia ALL globally. The amount of new cases reported each year is around 1.7 per 100,000 men & women per year. The American Cancer Institute has estimated that there will be around 5,930 new cases of ALL in 2019, i.e. 3,280 in men and 2,650 in women. Furthermore, it was estimated that the number of ALL cases in the Asia-Pacific and South American countries should range from 0.4 to 2 per 100,000 population by 2020. There is an increase in…

  • Anti Depressant market
    Pharmaceutical and Healthcare

    Anti Depressant Market Size, Share, Trends and Analysis

    Anti Depressant Market Anti Depressant Market Overview: The major factors for the growth of the global antidepressant market include rising cases of depression, increasing awareness of depression, and the emergence of new biologics. Overall, depression affects more than 300 million people across all age groups, and this amount is growing at a rapid rate. The increase in the number of young adults affected by some form of depression is as high as 8%. Depression due to factors such as social isolation and stressful job environment has contributed the most to increasing the amount of people suffering from depression. It is expected that the number of people falling prey to depression…

  • Oral Anti Diabetes Market
    Pharmaceutical and Healthcare

    Oral Anti Diabetes Market Industry Reports and Forecast

    Oral Anti Diabetes Market Oral Anti Diabetes Market Overview: The global market for oral anti-diabetes drugs is estimated at USD 39.2 billion in 2019 and is increasing as a result of the increase in the population of type 2 diabetes. Approximately 10% of cases of diabetes globally contribute to type 1 diabetes, and 90 percent of cases of diabetes contribute to type 2 diabetes. The number of people with diabetes is likely to achieve 592 million by 2035. In 2013, the global economic cost of diabetes is estimated at USD 548 billion. Thus, the rise in the prevalence of diabetes worldwide is probable to generate vast demand for diabetes drugs.…